Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal study

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):291-5. doi: 10.1097/00042560-199804010-00001.

Abstract

HIV-1 RNA and neopterin levels were observed longitudinally for 20 to 68 months (mean, 37.5 months) in cerebrospinal fluid (CSF) and serum in 15 HIV-1-infected patients not receiving antiretroviral treatment. During the course of infection the HIV-1 RNA levels increased significantly in CSF, from a mean of 3.08 to 3.51 log10 copies RNA/ml (p < .01). A significant positive correlation was found between the CSF levels of HIV-I RNA and neopterin (rs = 0.54; p < .001), which increased from 13.6 to 19.6 nmol/L (p < .01). No significant changes in HIV-1 RNA or neopterin levels were found in serum. We suggest that the increase of CSF viral load with time in HIV-1 infection triggers an intrathecal immune activation reflected by increased CSF levels of neopterin. These results are in accordance with the theory that a chronic immune stimulation within the central nervous system (CNS) is involved in the pathogenesis of neurologic HIV-1 disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • CD4 Lymphocyte Count
  • Cerebrospinal Fluid / virology*
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • HIV Infections / cerebrospinal fluid
  • HIV Infections / immunology
  • HIV Infections / virology*
  • HIV-1 / genetics
  • HIV-1 / immunology
  • HIV-1 / physiology*
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Neopterin / blood
  • Neopterin / cerebrospinal fluid
  • Polymerase Chain Reaction
  • RNA, Viral / blood
  • RNA, Viral / cerebrospinal fluid*
  • Viral Load*

Substances

  • RNA, Viral
  • Neopterin